NEW YORK ( TheStreet) -- Cell Therapeutics (Nasdaq: CTIC) hit a new 52-week low Wednesday as it is currently trading at $1.25, below its previous 52-week low of $1.26 with 393,889 shares traded as of 10:47 a.m. ET. Average volume has been 2.5 million shares over the past 30 days. Cell has a market cap of $258.5 million and is part of the health care sector and drugs industry. Shares are down 42.5% year to date as of the close of trading on Tuesday. Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for the treatment of cancer.
- Practice your CTIC trading strategies and win cash in our stock game.